von Willebrand factor links primary hemostasis to innate immunity

Authors: Drakeford, C; Aguila, S; Roche, F; Hokamp, K; Fazavana, J; Cervantes, MP; Curtis, AM; Hawerkamp, HC; Dhami, SP; Charles-Messance, H; Hackett, EE; Chion, A; Ward, S; Ahmad, A; Schoen, I; Breen, E; Keane, J; Murphy, R; Preston, RJ; O’Sullivan, JM; Sheedy, FJ; Fallon, P; O’Donnell, JS

Affiliations: Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Sch Pharm & Biomol Sci PBS, Dublin, Ireland. Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, IMIB Arrixaca, Murcia, Spain. Trinity Coll Dublin, Sch Genet & Microbiol, Smurfit Inst Genet, Dublin, Ireland., Sch Pharm & Biomol Sci PBS, Dublin 2, Ireland.

Publications: Nature Communications ; 2022 ; 13

Abstract: The plasma multimeric glycoprotein von Willebrand factor (VWF) plays a critical role in primary hemostasis by tethering platelets to exposed collagen at sites of vascular injury. Recent studies have identified additional biological roles for VWF, and in particular suggest that VWF may play an important role in regulating inflammatory responses. However, the molecular mechanisms through which VWF exerts its immuno-modulatory effects remain poorly understood. In this study, we report that VWF binding to macrophages triggers downstream MAP kinase signaling, NF-kappa B activation and production of pro-inflammatory cytokines and chemokines. In addition, VWF binding also drives macrophage M1 polarization and shifts macrophage metabolism towards glycolysis in a p38-dependent manner. Cumulatively, our findings define an important biological role for VWF in modulating macrophage function, and thereby establish a novel link between primary hemostasis and innate immunity. von Willebrand factor (VWF) plays a critical role in primary hemostasis following vascular injury by tethering platelets to exposed collagen. Here, VWF binding to macrophages is shown to trigger NF-kappa B activation and induce pro-inflammatory responses.